TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pharmarelations AB
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
335,021
|
283,718
|
201,529 |
Financial expenses |
437
|
326
|
115 |
Earnings before taxes |
21,999
|
21,881
|
19,462 |
EBITDA |
21,561
|
22,082
|
19,609 |
Total assets |
121,974
|
92,896
|
72,937 |
Current assets |
121,389
|
92,274
|
72,396 |
Current liabilities |
47,030
|
34,833
|
31,045 |
Equity capital |
70,042
|
49,723
|
32,682 |
- share capital |
107
|
95
|
98 |
Employees (average) |
227
|
197
|
146 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
57.4%
|
53.5%
|
44.8% |
Turnover per employee |
1,476
|
1,440
|
1,380 |
Profit as a percentage of turnover |
6.6%
|
7.7%
|
9.7% |
Return on assets (ROA) |
18.4%
|
23.9%
|
26.8% |
Current ratio |
258.1%
|
264.9%
|
233.2% |
Return on equity (ROE) |
31.4%
|
44.0%
|
59.5% |
Change turnover |
31,171
|
88,246
|
46,922 |
Change turnover % |
10%
|
45%
|
30% |
Chg. No. of employees |
30
|
51
|
34 |
Chg. No. of employees % |
15%
|
35%
|
30% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.